Indo Rama Synthetics (India) Ltd Guidance Report - SOIC x StockScans Report

as of Oct 2026

  1. FY28/FY29 EBITDA margins - 11-12%, double digits Pending - At the Q2 FY27 call, on FY28/FY29 EBITDA margins of 11-12%, management said: "Definitely from 9.9%, we will target on double digits. It should not go down". H1 FY27 EBITDA margin was 9.9% and FY26 was 7.5%; no FY28/FY29 figures are reported yet.
  2. Specialty filament and fibre expansion - \~₹200 crore, CY27 commercial operations On track - At the Q2 FY27 call, management announced Board approval of \~₹200 crore across the company and subsidiary Indorama Ventures Yarns for specialty filament and fiber at Butibori, with commercial operations within Calendar Year 2027, \~15% top-line and \~20% EBITDA growth and sub-2-year payback. Capacity details include \~115-120 TPD specialty conversion plus \~70 TPD of new filament machines; no commissioning date has yet been reached.
  3. EBITDA margin maintenance - 9.9% for next 2 quarters Pending - At the Q2 FY27 call, management said the 9.9% EBITDA margin achieved in H1 FY27 would be maintained in the next 2 quarters - "we don't see any big change". H1 FY27 margin was 9.9%, with Q2 FY27 at 8.8%; Q3 and Q4 FY27 are not yet reported.
  4. FY27 EBITDA guidance - ₹400+ crore On track - At the Q2 FY27 call, management gave firm FY27 EBITDA guidance of "400 plus" crores. H1 FY27 EBITDA was ₹225.7 crore, up 24.9% YoY, with Q2 at ₹117.7 crore on an 8.8% margin; the company needs \~₹174 crore in H2 to reach ₹400 crore.
  5. FY27 volume guidance - \~4 lakh tons, return to 4.75 lakh+ tons in FY28 On track - At the Q2 FY27 call, management guided FY27 volumes of \~4 lakh tons despite Q1/Q2 disruption and a return to 4,75,000+ tons in FY28 - 475k described as "the minimum". FY26 volume was \~4,75,000 tons; H1 FY27 total income fell 9.7% YoY on supply chain issues, with filament and fiber at 100% and PET at 60%.
  6. ₹600 crore expansion plan - MMF growth potential Delivered - In the FY21 Annual Report, the company stated it had embarked on an expansion plan of about ₹600 crores considering the growth potential of MMF, reiterated in the FY22 Annual Report. Capex of ₹628 cr was deployed across FY23-FY26, and the debottlenecking to 1,920 TPD, 2.28 lakh TPA PET resin and 39 texturising machines (DTY capacity 1.75 lakh TPA) were commissioned by June 2023.
  7. FY21 capacity utilisation - more than 60% vs 42% in FY20 Missed - In the FY20 Annual Report, management targeted capacity utilisation of more than 60% during FY 2020-21, versus 42% in FY 2019-20, supported by cost-efficiency initiatives and IVL support. Later disclosure shows FY21 utilisation of 43%; FY21 standalone total income was ₹2,043.59 crore and EBITDA improved to ₹113.30 crore from ₹0.66 crore.